EE200300047A - Mittepeptiidsed CCR1-retseptori antagonistid kombinatsioonis tsüklosporiiniga A südametransplantaadi hülgamisreaktsiooni raviks - Google Patents

Mittepeptiidsed CCR1-retseptori antagonistid kombinatsioonis tsüklosporiiniga A südametransplantaadi hülgamisreaktsiooni raviks

Info

Publication number
EE200300047A
EE200300047A EEP200300047A EEP200300047A EE200300047A EE 200300047 A EE200300047 A EE 200300047A EE P200300047 A EEP200300047 A EE P200300047A EE P200300047 A EEP200300047 A EE P200300047A EE 200300047 A EE200300047 A EE 200300047A
Authority
EE
Estonia
Prior art keywords
transplant rejection
ciclosporin
heart transplant
treatment
combination
Prior art date
Application number
EEP200300047A
Other languages
English (en)
Estonian (et)
Inventor
Horuk Richard
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200300047A publication Critical patent/EE200300047A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200300047A 2000-07-31 2001-07-31 Mittepeptiidsed CCR1-retseptori antagonistid kombinatsioonis tsüklosporiiniga A südametransplantaadi hülgamisreaktsiooni raviks EE200300047A (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22205300P 2000-07-31 2000-07-31
US23128200P 2000-09-08 2000-09-08
US09/915,411 US6740636B2 (en) 2000-07-31 2001-07-25 Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
PCT/US2001/023862 WO2002009762A2 (en) 2000-07-31 2001-07-31 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection

Publications (1)

Publication Number Publication Date
EE200300047A true EE200300047A (et) 2004-10-15

Family

ID=27397025

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300047A EE200300047A (et) 2000-07-31 2001-07-31 Mittepeptiidsed CCR1-retseptori antagonistid kombinatsioonis tsüklosporiiniga A südametransplantaadi hülgamisreaktsiooni raviks

Country Status (28)

Country Link
US (1) US6740636B2 (de)
EP (1) EP1305047B1 (de)
JP (1) JP2004530630A (de)
KR (1) KR20030048000A (de)
CN (1) CN1655818A (de)
AT (1) ATE330634T1 (de)
AU (2) AU7807301A (de)
BG (1) BG107502A (de)
BR (1) BR0113140A (de)
CA (1) CA2417636A1 (de)
CY (1) CY1105321T1 (de)
DE (1) DE60120986T2 (de)
DK (1) DK1305047T3 (de)
EE (1) EE200300047A (de)
ES (1) ES2261447T3 (de)
HR (1) HRP20030121A2 (de)
HU (1) HUP0300686A3 (de)
IL (1) IL153933A0 (de)
LV (1) LV13033B (de)
MX (1) MXPA03000836A (de)
NO (1) NO20030475L (de)
NZ (1) NZ523688A (de)
PL (1) PL364521A1 (de)
PT (1) PT1305047E (de)
SI (1) SI21123A (de)
SK (1) SK1222003A3 (de)
WO (1) WO2002009762A2 (de)
YU (1) YU6703A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160761A0 (en) 2001-10-19 2004-08-31 Isotechnika Inc Novel cyclosporin analog microemulsion preconcentrates
EP1660089A1 (de) * 2003-08-22 2006-05-31 Schering Aktiengesellschaft Chemokin-hemmende piperazin-derivate und ihre verwendung zur behandlung von myokarditis
US7917195B2 (en) 2004-03-05 2011-03-29 Lifesciences Solutions LLC Systems, methods and computer program products for heart monitoring
US10499828B2 (en) * 2004-03-05 2019-12-10 Lifescience Solutions, Llc System and method for heart monitoring
US8103065B2 (en) * 2006-01-05 2012-01-24 Lifescience Solutions Llc Assessment of medical conditions
US20110009758A1 (en) * 2009-07-10 2011-01-13 Lifescience Solutions Llc System and method for heart monitoring

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
WO1998038167A1 (en) 1997-02-26 1998-09-03 Pfizer Inc. Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
AU2331999A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
CA2318088A1 (en) 1998-01-21 1999-07-29 Yoshisuke Nakasato Chemokine receptor antagonists and methods of use therefor
UA57824C2 (uk) 1998-02-05 2003-07-15 Пфайзер Продактс Інк. Похідні дигідроксигексанової кислоти, фармацевтична композиція, що їх містить (варіанти), та спосіб лікування (варіанти)
EP1000626A1 (de) 1998-09-18 2000-05-17 Applied Research Systems ARS Holding N.V. Kombination von chemokin-rezeptor antagonisten und cyclosporin zur therapie
CA2360672A1 (en) 1999-01-29 2000-08-03 Wayne W. Hancock Methods for preventing graft rejection and ischemia-reperfusion injury

Also Published As

Publication number Publication date
CA2417636A1 (en) 2002-02-07
LV13033B (en) 2004-02-20
EP1305047B1 (de) 2006-06-21
HUP0300686A2 (hu) 2003-08-28
US6740636B2 (en) 2004-05-25
AU2001278073B2 (en) 2005-06-30
HUP0300686A3 (en) 2005-03-29
SK1222003A3 (en) 2003-09-11
CY1105321T1 (el) 2010-03-03
PT1305047E (pt) 2006-11-30
YU6703A (sh) 2006-05-25
SI21123A (sl) 2003-08-31
US20020039997A1 (en) 2002-04-04
EP1305047A2 (de) 2003-05-02
HRP20030121A2 (en) 2005-02-28
BG107502A (en) 2003-07-31
DK1305047T3 (da) 2006-10-23
AU7807301A (en) 2002-02-13
NO20030475L (no) 2003-03-28
CN1655818A (zh) 2005-08-17
PL364521A1 (en) 2004-12-13
IL153933A0 (en) 2003-07-31
ES2261447T3 (es) 2006-11-16
NO20030475D0 (no) 2003-01-30
WO2002009762A2 (en) 2002-02-07
BR0113140A (pt) 2003-06-24
WO2002009762A3 (en) 2003-01-09
ATE330634T1 (de) 2006-07-15
KR20030048000A (ko) 2003-06-18
DE60120986D1 (de) 2006-08-03
DE60120986T2 (de) 2006-11-23
NZ523688A (en) 2005-04-29
MXPA03000836A (es) 2003-06-06
JP2004530630A (ja) 2004-10-07

Similar Documents

Publication Publication Date Title
ATE384724T1 (de) Cyclopropylverbindungen als ccr5 antagonisten
TW200626138A (en) Heterocyclic derivatives and their use as therapeutic agents
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
TR200100172T2 (tr) Oral katı doz formunda eprosartan içeren biyolojik bakımdan kuvvetlendirilmiş formülasyonlar
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
SG149872A1 (en) Antagonists of the bradykinin b1 receptor
SV2002000235A (es) Composiciones farmaceuticas que comprenden valdecoxib
EE200300047A (et) Mittepeptiidsed CCR1-retseptori antagonistid kombinatsioonis tsüklosporiiniga A südametransplantaadi hülgamisreaktsiooni raviks
IL154358A0 (en) Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
SE9902935D0 (sv) Pharmaceutical compositions
MXPA04002389A (es) Combinacion de un antagonista del receptor de adenosian a2a y un antidepresivo o ansiolitico.
NO20013459D0 (no) Anvendelse av agiotensin II reseptorantagonister ved behandling av akutt myokardinfarkt
LT2003015A (en) Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
ATE323532T1 (de) Nicht-peptidische ccr1-rezeptor-antagonisten zur behandlung der progressiven nierenfibrose
ATE277639T1 (de) Zusammensetzungen von adenosin a1 agonisten und 5ht3 agonisten
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
EE04705B1 (et) Kemokiinretseptori antagonisti kasutamine kombinatsioonis tsüklosporiiniga farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud siirdatud organite, kudede või rakkude hülgamisreaktsiooniraviks või vältimiseks
AR018825A1 (es) Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas
WO2001079193A3 (en) Substituted hydrazinyl heteroaromatic inhibitors of thrombin
TNSN06113A1 (en) Antagonists of the bradykinin b1 receptor
PE20001336A1 (es) Composicion que contiene un miorelajante y un antiinflamatorio no esteroideo para el tratamiento de afecciones dolorosas asociadas a contracturas o espamos musculares
PL1668027T3 (pl) Cykliczne peptydy działające jako antagoniści Urotensyny-II
ES2173023A1 (es) Composicion farmaceutica con actividad inmunosupresora